Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/karger/antiprogestin-mediated-inactivation-of-cytochrome-p450-3a4-eQ0dCIA2Q0
References (31)
-
Xiao-Jian Zhou, Xiao-Jian Zhou, X. Zhou-Pan, X. Zhou-Pan, Thérése Gauthier, M. Placidi, Patrick Maurel, Roger Rahmani (1993)
Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions.Biochemical pharmacology, 45 4
-
Graham Jang, S. Wrighton, Leslie Benet (1996)
Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes.Biochemical pharmacology, 52 5
-
T. Omura, R. Sato (1964)
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.The Journal of biological chemistry, 239
-
S. Grunberg, M. Weiss, I. Spitz, J. Ahmadi, A. Sadun, C. Russell, Lois Lucci, L. Stevenson (1991)
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.Journal of neurosurgery, 74 6
-
O. Heikinheimo, O. Ylikorkala, U. Turpeinen, P. Lähteenmäki (1990)
Pharmacokinetics of the antiprogesterone RU 486: no correlation to clinical performance of RU 486.Acta endocrinologica, 123 3
-
M. Franklin (1974)
The influence of cytochrome P-450 induction on the metabolic formation of 455-NM complexes from amphetamines.Drug metabolism and disposition: the biological fate of chemicals, 2 3
-
X. Zhou-Pan, SÃ Eric, Xiao-Jinn Zhou, M. Placidi, Patrick Maurel, Yves Barra, Roger Rahmani (1993)
Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.Cancer research, 53 21
-
D. Pessayre, V. Descatoire, M. Konstantinova-Mitcheva, J. Wandscheer, B. Cobert, R. Level, P. Benhamou, M. Jaouen, D. Mansuy (1981)
Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450.Biochemical pharmacology, 30 6
-
K. Greene, L. Kettel, S. Yen (1992)
Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.Fertility and sterility, 58 2
-
J. Werringloer, R. Estabrook (1975)
Heterogeneity of liver microsomal cytochrome P-450: the spectral characterization of reactants with reduced cytochrome P-450.Archives of biochemistry and biophysics, 167 1
-
James Harris, Atiqur Rahman, Br Kim, F. Guengerich, J. Collins (1994)
Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.Cancer research, 54 15
-
P. Lähteenmäki, O. Heikinheimo, H. Croxatto, I. Spitz, D. Shoupe, L. Birgerson, T. Luukkainen (1987)
Pharmacokinetics and metabolism of RU 486.Journal of steroid biochemistry, 27 4-6
-
G. Bakker, B. Setyono‐Han, H. Portengen, F. Jong, J. Foekens, J. Klijn (1990)
Treatment of breast cancer with different antiprogestins: Preclinical and clinical studiesThe Journal of Steroid Biochemistry and Molecular Biology, 37
-
M. Relling, R. Evans, C. Dass, Dominic Desiderio, J. Němec (1992)
Human cytochrome P450 metabolism of teniposide and etoposide.The Journal of pharmacology and experimental therapeutics, 261 2
-
M. Lin, M. Kawachi, F. Lin, M. Stallcup, S. Grunberg (1995)
Growth inhibition of androgen‐insensitive human prostate carcinoma cells by a 19‐norsteroid derivative agent, mifepristoneThe Prostate, 26
-
M. Franklin (1976)
A new class of inhibitory cytochrome P-450 complexes formed during metabolism: a comparison with amphetamine and SKF 525-A type complexes.Chemico-biological interactions, 14 3-4
-
(1989)
Analysis and characterization of enzymes; in Hayes AW (ed): Principles and Methods of Toxicology -
D. Pessayre, M. Konstantinova-Mitcheva, V. Descatoire, B. Cobert, J. Wandscheer, R. Level, G. Feldmann, D. Mansuy, J. Benhamou (1981)
Hypoactivity of cytochrome P-450 after triacetyloleandomycin administration.Biochemical pharmacology, 30 6
-
M. Batista, T. Cartledge, A. Zellmer, Maria Merino, Constantine Axiotis, D. Loriaux, Lynnette Nieman (1992)
Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.American journal of obstetrics and gynecology, 167 1
-
C. Puri, P. Look (1991)
Newly Developed Competitive Progesterone Antagonists for Fertility ControlFrontiers of Hormone Research, 19
-
Martin Schneider, H. Michna, Y. Nishino, M. Etreby (1990)
Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer modelsThe Journal of Steroid Biochemistry and Molecular Biology, 37
-
M. Franklin (1991)
Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds.Methods in enzymology, 206
-
M. Hirata, B. Lindeke, S. Orrenius (1979)
Cytochrome P450 product complexes and glutathione consumption produced in isolated hepatocytes by norbenzphetamine and its N-oxidized congeners.Biochemical pharmacology, 28 4
-
Graham Jang, Leslie Benet (1997)
Cytochrome P4503A4-mediated N-demethylation of the antiprogestins lilopristone and onapristone.Drug metabolism and disposition: the biological fate of chemicals, 25 10
-
M. Buening, M. Franklin (1976)
SKF 525-A inhibition, induction, and 452-nm complex formation.Drug metabolism and disposition: the biological fate of chemicals, 4 3
-
C. Bensoussan, Marcel Delaforge, Daniel Mansuy (1995)
Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs.Biochemical pharmacology, 49 5
-
M. Buening, M. Franklin (1974)
The formation of complexes absorbing at 455 nm from cytochrome P-450 and metabloites of compounds related to SKF 525-A.Drug metabolism and disposition: the biological fate of chemicals, 2 4
-
M. Hirata, J. Högberg, H. Thor, S. Orrenius (2009)
Cytochrome P-450-product complexes produced by amphetamine derivatives: a comparative study with isolated liver microsomes and hepatocytes.Acta pharmacologica et toxicologica, 41 2
-
V. Wacher, Chi‐Yuan Wu, L. Benet (1995)
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapyMolecular Carcinogenesis, 13
-
Françoise Jacolot, Isabelle Simon, Y. Dréano, Philippe Beaune, Christian Riché, François Berthou (1991)
Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes.Biochemical pharmacology, 41 12
-
J. Schenkman, B. Wilson, D. Cinti (1972)
Dimethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A)--in vivo and in vitro effects of metabolism by rat liver microsomes--formation of an oxygenated complex.Biochemical pharmacology, 21 17
- Publisher
- Karger
- Copyright
- © 1998 S. Karger AG, Basel
- ISSN
- 0031-7012
- eISSN
- 1423-0313
- DOI
- 10.1159/000028193
- Publisher site
- See Article on Publisher Site
Abstract
Based on previous observations of very short periods of linearity for antiprogestin metabolite formation and the presence of a common tertiary amine moiety in each compound as the principal site of their metabolism, we hypothesized that mifepristone, lilopristone and onapristone are oxidized by cytochrome P450 (CYP) 3A4 to reactive nitroso species that complex the heme of the enzyme, thereby inactivating it. Upon preincubation with human liver microsomes in the presence (but not the absence) of NADPH, mifepristone inhibited midazolam 1′-hydroxylation, a marker of CYP3A4 catalytic activity, very potently (IC<sub>50</sub> ∼3.5 µmol/l) and extensively (by ∼87%). Lilopristone and onapristone also displayed NADPH and time-dependent inactivation of CYP3A4 with characteristics very similar to mifepristone. These data support antiprogestin-mediated inactivation of CYP3A4 and suggest the potential for drug-drug interactions and time-dependent nonlinearities in pharmacokinetics upon their long-term administration.
Journal
Pharmacology – Karger
Published: Mar 1, 1998
Keywords: Cytochrome P450 3A4; Antiprogestins; Mifepristone; Lilopristone; Onapristone; Enzyme inactivation